Nammi Therapeutics
PrivateLast Round
Series B
Nov 8, 2024
Total Funding Raised
$82.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nammi Therapeutics is a biotechnology company that develops innovative immunotherapy solutions, including masked immunocytokines and nanoparticle-based prodrugs, for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nammi Therapeutics Comparables
Compare Nammi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Audax Biosciences | 81% | |
| Deka Biosciences | 81% | |
| Werewolf Therapeutics | 81% |
For institutional investors. Book with your work email.
Nammi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2024 | ||||
| Series B | Aug 6, 2024 | ||||
| Grant | Dec 15, 2022 | ||||
| Seed | Jan 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nammi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 39% MoM.
- Jul 26, 2026
Monthly visitors grew 35% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Nammi Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nammi Therapeutics's valuation, stock price, and market status.
Is Nammi Therapeutics a public or private company?
Nammi Therapeutics is a private company.
What is the current stock price of Nammi Therapeutics?
Nammi Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nammi Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nammi Therapeutics worth (valuation)?
Valuation information for Nammi Therapeutics is not publicly available.
Can I buy Nammi Therapeutics stock?
Nammi Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nammi Therapeutics's last funding round?
Nammi Therapeutics's most recent funding round was Series B on November 8, 2024.
Who are the main investors in Nammi Therapeutics?
Key investors in Nammi Therapeutics include California Institute for Regenerative Medicine.
Will Nammi Therapeutics IPO soon?
No public IPO plans have been announced for Nammi Therapeutics.
How can I track Nammi Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nammi Therapeutics's shares on secondary markets.